Andrew Walsh's appointment, with his solid financial operati...

Andrew Walsh's appointment, with his solid financial operations experience, is a key move in Annovis Bio's growth strategy. His skills are expected to be crucial for the firm's future success, particularly as it prepares for essential clinical trial data in 2024.